INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -71.4% | 4,000 | -33.3% | 0.00% | -60.0% |
| Q1 2022 | $21,000 | -30.0% | 6,000 | -1.6% | 0.01% | -28.6% |
| Q4 2021 | $30,000 | +3.4% | 6,100 | +48.8% | 0.01% | 0.0% |
| Q3 2021 | $29,000 | -23.7% | 4,100 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $38,000 | +100.0% | 4,100 | +95.2% | 0.01% | +100.0% |
| Q1 2021 | $19,000 | +5.6% | 2,100 | +5.0% | 0.01% | 0.0% |
| Q4 2020 | $18,000 | -21.7% | 2,000 | 0.0% | 0.01% | -37.5% |
| Q3 2020 | $23,000 | +21.1% | 2,000 | +100.0% | 0.01% | +14.3% |
| Q2 2020 | $19,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |